Abstract
Folate metabolism is central to cell proliferation and a target of commonly used cancer chemotherapeutics. In particular, the mitochondrial folate-coupled metabolism is thought to be important for proliferating cancer cells. The enzyme MTHFD2 in this pathway is highly expressed in human tumors and broadly required for survival of cancer cells. Although the enzymatic activity of the MTHFD2 protein is well understood, little is known about its larger role in cancer cell biology. We here report that MTHFD2 is co-expressed with two distinct gene sets, representing amino acid metabolism and cell proliferation, respectively. Consistent with a role for MTHFD2 in cell proliferation, MTHFD2 expression was repressed in cells rendered quiescent by deprivation of growth signals (serum) and rapidly re-induced by serum stimulation. Overexpression of MTHFD2 alone was sufficient to promote cell proliferation independent of its dehydrogenase activity, even during growth restriction. In addition to its known mitochondrial localization, we found MTHFD2 to have a nuclear localization and co-localize with DNA replication sites. These findings suggest a previously unknown role for MTHFD2 in cancer cell proliferation, adding to its known function in mitochondrial folate metabolism.
Introduction
Cancer cells are characterized by significant metabolic reprogramming, particularly a heavy reliance on the folate cycle to generate the essential building blocks for DNA and protein synthesis. MTHFD2 (methylenetetrahydrofolate dehydrogenase 2) has long been considered a prime oncology target because it is highly expressed in nearly all human tumors while remaining almost entirely absent in healthy adult tissues.
Traditionally, MTHFD2 was understood to reside strictly in the mitochondria, where it manages "one-carbon" units. However, a lingering mystery remained: when MTHFD2 is depleted, cancer cells die in a manner that cannot be rescued by simply providing the metabolic products the enzyme usually generates, such as glycine or formate. This discrepancy suggested that MTHFD2 possesses a secondary, non-enzymatic "moonlighting" function essential for cancer survival. This study aimed to identify and characterize this hidden role.
Methods
The researchers combined large-scale computational data mining with traditional cell biology techniques:
- Computational Co-expression Analysis: A meta-analysis was performed on 8,097 microarray datasets from the NCBI Gene Expression Omnibus (GEO) across human, mouse, and rat species to identify genes consistently co-regulated with MTHFD2.
- Inducible Protein Expression: HCT-116 cancer cells were engineered to express either wild-type MTHFD2 or a "dehydrogenase-dead" mutant (R204A). This mutant is structurally identical but lacks enzymatic activity, allowing researchers to test if the protein's physical presence drives proliferation independently of its chemical output.
- Subcellular Localization: Confocal microscopy, subcellular fractionation, and re-analysis of nuclear proteome datasets were used to pinpoint the protein's location within the cell.
- DNA Synthesis Tracking: EdU labeling was used to determine if MTHFD2 co-localizes with active sites of DNA replication.
Results and Discussion
Identification of Dual Gene Clusters
The computational analysis revealed that MTHFD2 is tightly co-expressed with two distinct gene sets. One cluster is associated with amino acid metabolism and the ATF4-mediated stress response, while the other is linked to cell proliferation and the cell cycle (specifically S and G2/M phases). This dual identity suggests that MTHFD2 bridges the gap between nutrient availability and the decision to divide.
Non-Enzymatic Promotion of Growth
One of the most significant findings was that MTHFD2 promotes cell growth independently of its known metabolic function. Overexpression of the "dehydrogenase-dead" mutant promoted cell proliferation as effectively as the wild-type enzyme, even under serum starvation conditions (0.2% serum) that typically halt cell growth. This proves that MTHFD2's role in driving cancer is not solely dependent on its chemical reaction but involves a structural or regulatory function of the protein itself.
Nuclear Localization and DNA Replication
While long thought to be exclusively mitochondrial, the study confirmed that MTHFD2 is also a nuclear protein. By using Leptomycin B to block nuclear export, the authors demonstrated that MTHFD2 actively traffics in and out of the nucleus. Furthermore, MTHFD2 was found to co-localize with newly synthesized DNA, suggesting it may be a direct component of the machinery that replicates the genome. This nuclear presence was further validated in human breast tumor and melanoma samples via immunohistochemical staining.
Conclusion
These findings reveal that MTHFD2 is a multi-functional protein with a critical role in the cell nucleus. Beyond its established function in mitochondrial folate metabolism, MTHFD2 promotes cancer cell proliferation through a non-enzymatic mechanism and associates with DNA replication sites. While the exact molecular mechanism—whether it acts as a scaffold, a transcriptional regulator, or a DNA repair factor—remains to be elucidated, these results suggest that future therapeutic strategies should aim to inhibit both the metabolic and the nuclear functions of MTHFD2.
Summary updated